Impact of Lung Cancer Screening With Chest Scans Combined With Coaching on Smoking Cessation in Heavy Smokers

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-79
SponsorHôpital Cantonal de Fribourg

About this trial

Lung cancer is common and serious, but when detected early, the chances of recovery are significantly better. Tobacco use is the leading cause. To help people break free from smoking, the Fribourg Cantonal Hospital (HFR), the Center for Tobacco Prevention (CIPRET), and the Fribourg Cancer League are joining forces in the STOP-LungCancer study (Smoking Termination Outcomes with Pulmonary Low Dose Computed Tomography for Lung Cancer Screening).

What is the goal of this study? The investigators want to determine whether seeing and understanding images of the participants' own lungs helps participants quit smoking for good. Smoking cessation will be verified at 6 months using a breath test (measuring carbon monoxide), followed by a 2-year follow-up.

How does participation work? The study is open to 116 residents of the canton of Fribourg aged 50 to 79 who are heavy smokers and motivated to quit.

The program includes:

1. Personalized support: 4 smoking cessation coaching sessions organized by CIPRET. 2. Lung computed tomography (CT) scans: 3 exams spaced one year apart. This scan involves no needles or injections. The radiation dose is very low, about 0.6 millisieverts (mSv) per scan, and the associated risk is considered very low. 3. A review of the images with a doctor: During dedicated consultations, a thoracic radiologist reviews the participant's own computed tomography (CT) scans with the participant to explain the condition of the lungs and heart.

What are the benefits? Participants receive both tailored support to quit smoking and close monitoring to detect any potential issues at a very early stage.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Residence in the canton of Fribourg

Willingness to quit smoking

Current smoker: > or = 20 packs years

Disqualifiers

Previous diagnosis of cancer

Major medical problems (Eastern Cooperative Oncology Group, ECOG ≥ 2)

Chest computed tomography (CT) scan in the last 12 months

Hemoptysis or unintentional weight loss > 7 kilograms (kg) in the last year

Trial design

Design model

Single group

Treatments tested in this trial

  • Image-Based Counseling

    Behavioral

    Face-to-face physician consultations where a thoracic radiologist reviews the participant's own computed tomography (CT) scans with the participant to explain lung and cardiovascular health, creating a visual "teachable moment".

  • Smoking Cessation Coaching

    Behavioral

    Four structured behavioral counseling sessions delivered by certified tobacco cessation experts of the Center for Tobacco Prevention (CIPRET), personalized to support long-term abstinence.

  • Low-Dose Chest Computed Tomography (LDCT)

    Radiation

    Low-dose chest computed tomography (LDCT) scans without intravenous contrast at baseline, 12 months, and 24 months, and additional follow-up LDCT when indicated by the screening result (Lung Computed Tomography Screening Reporting and Data System \[Lung-RADS\] category 3).

Treatment groups

116 Participants
are divided into 1 treatment group
Group A: Combined Low-Dose Computed Tomography Screening and Smoking Cessation CoachingExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

6-Month Smoking Abstinence Rate

Proportion of participants who achieve smoking abstinence at 6 months after the first chest computed tomography (CT). Abstinence is self-reported and objectively validated using exhaled carbon monoxide (CO) measurement.

Time frame
6 months after the first chest computed tomography (CT)

Secondary outcomes

1

Smoking Abstinence Rate at 12 Months

Proportion of participants reporting smoking abstinence at the 12-month visit, confirmed by exhaled carbon monoxide (CO) measurement.

Time frame
12 months after the first chest computed tomography
2

Smoking Abstinence Rate at 24 Months

Proportion of participants reporting smoking abstinence at the 24-month visit, confirmed by exhaled carbon monoxide (CO) measurement.

Time frame
24 months after the first chest computed tomography
3

Detection Rate of Lung Nodules and Lung Cancer

Proportion of participants with positive low-dose computed tomography (LDCT) findings requiring further diagnostic follow-up or tissue biopsy, categorized according to the standardized Lung Computed Tomography Screening Reporting and Data System (Lung-RADS) assessment categories.

Time frame
Baseline, 12 months, and 24 months
4

Prevalence of Relevant Incidental Findings on Chest Computed Tomography

Proportion of relevant non-lung-nodule incidental findings detected on low-dose chest computed tomography, such as smoking-related lung disease, cardiac abnormalities and other findings unrelated to smoking.

Time frame
Baseline, 12 months, and 24 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hôpital Cantonal de Fribourg

Lead sponsor

CIPRET Fribourg (Centre d'information pour la prévention du tabagisme)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: